The Dysbindin Gene (DTNBP1) Is Associated with Methamphetamine Psychosis

Makiko Kishimoto, Hiroshi Ujike, Yasuko Motohashi, Yuji Tanaka, Yuko Okahisa, Tatsuya Kotaka, Mutsuo Harano, Toshiya Inada, Mitsuhiko Yamada, Tokutaro Komiyama, Toru Hori, Yoshimoto Sekine, Nakao Iwata, Ichiro Sora, Masaomi Iyo, Norio Ozaki, Shigetoshi Kuroda

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Background: The dysbindin (DTNBP1 [dystrobrevin-binding protein 1]) gene has repeatedly been shown to be associated with schizophrenia across diverse populations. One study also showed that risk haplotypes were shared with a bipolar disorder subgroup with psychotic episodes, but not with all cases. DTNBP1 may confer susceptibility to psychotic symptoms in various psychiatric disorders besides schizophrenia. Methods: Methamphetamine psychosis, the psychotic symptoms of which are close to those observed in schizophrenia, was investigated through a case (n = 197)-control (n = 243) association analyses of DTNBP1. Results: DTNBP1 showed significant associations with methamphetamine psychosis at polymorphisms of P1635 (rs3213207, p = .00003) and SNPA (rs2619538, p = .049) and the three-locus haplotype of P1655 (rs2619539)-P1635-SNPA (permutation p = .0005). The C-A-A haplotype, which was identical to the protective haplotype previously reported for schizophrenia and psychotic bipolar disorders, was a protective factor (p = .0013, odds ratio [OR] = .62, 95% confidence interval [CI] .51-.77) for methamphetamine psychosis. The C-G-T haplotype was a risk for methamphetamine psychosis (p = .0012, OR = 14.9, 95% CI 3.5-64.2). Conclusions: Our genetic evidence suggests that DTNBP1 is involved in psychotic liability not only for schizophrenia but also for other psychotic disorders, including substance-induced psychosis.

Original languageEnglish
Pages (from-to)191-196
Number of pages6
JournalBiological Psychiatry
Volume63
Issue number2
DOIs
Publication statusPublished - Jan 15 2008

Keywords

  • Akt1
  • DTNBP1
  • dysbindin
  • methamphetamine psychosis
  • substance dependence

ASJC Scopus subject areas

  • Biological Psychiatry

Fingerprint Dive into the research topics of 'The Dysbindin Gene (DTNBP1) Is Associated with Methamphetamine Psychosis'. Together they form a unique fingerprint.

  • Cite this

    Kishimoto, M., Ujike, H., Motohashi, Y., Tanaka, Y., Okahisa, Y., Kotaka, T., Harano, M., Inada, T., Yamada, M., Komiyama, T., Hori, T., Sekine, Y., Iwata, N., Sora, I., Iyo, M., Ozaki, N., & Kuroda, S. (2008). The Dysbindin Gene (DTNBP1) Is Associated with Methamphetamine Psychosis. Biological Psychiatry, 63(2), 191-196. https://doi.org/10.1016/j.biopsych.2007.03.019